Sponsored By

Another Bombshell for Guidant ICDs

An FDA analysis conducted last year concluded that Guidant implantable cardioverter-defibrillators were 10 times more likely to fail than the company had let on, Bloomberg News reports, citing documents unsealed as part of a product-liability lawsuit against Guidant (now part of Boston Scientific) in Texas. When Guidant began its recall, it said that no more than 292 of the devices would fail. But the FDA analysis placed that figure at around 3200.